Graf Akcie AGIO (Agios Pharmaceuticals Inc). Diskuze k akciím AGIO. Aktuální informace AGIO.

Základní informace o společnosti Agios Pharmaceuticals Inc (Akcie AGIO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.89B
Hodnota podniku (EV) 1.1B
Tržby 78.751M
EBITDA -355.29
Zisk 1.591B
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 2.06
Forward P/E N/A
EV/Sales 13.96
EV/EBITDA N/A
EV/EBIT 0.69
PEG N/A
Price/Sales 36.71
P/FCF N/A
Price/Book 7.24
Účetní hodnota na akcii 6.46
Hotovost na akcii 9.26
FCF vůči ceně -12.56 %
Počet zaměstnanců 562
Tržba na zaměstnance 140.126k
Profit margin -161.11 %
Operating margin -463.74 %
Gross margin 98.62 %
EBIT margin 2,021.01 %
EBITDA margin -451.16 %
EPS - Zisk na akcii 22.70
EPS - Kvartální růst 7.63 %
EPS - Očekávaný růst příští rok 11.19 %
Return on assets 103.94 %
Return on equity 129.96 %
ROIC -37.55 %
ROCE 87.74 %
Dluhy/Equity 1.14
Čistý dluh/EBITDA 11.96
Current ratio 28.07
Quick Ratio 28.07
Volatilita 3.15
Beta 0.72
RSI 56.17
Cílová cena analytiků 64
Známka akcie (dle analytiků) 1.29
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 58.951M
Procento shortovaných akcií 11.61 %
Short ratio 9.59 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie AGIO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$117.912$94.387$43.011$69.892$59.119$65.358
Cost Of Goods Sold$1.317$1.397----
Gross Profit$116.595$92.99$43.011$69.892$59.119$65.358
Research And Development Expenses$410.894$341.324$292.681$220.163$141.827$100.371
SG&A Expenses$132.034$114.145$71.124$50.714$35.992$19.12
Other Operating Income Or Expenses------
Operating Expenses$544.245$456.866$363.805$270.877$177.819$119.491
Operating Income$-426.333$-362.479$-320.794$-200.985$-118.7$-54.133
Total Non-Operating Income/Expense$14.861$16.451$6.124$2.514$0.968$0.203
Pre-Tax Income$-411.472$-346.028$-314.67$-198.471$-117.732$-53.93
Income Taxes-----$-0.426
Income After Taxes$-411.472$-346.028$-314.67$-198.471$-117.732$-53.504
Other Income------
Income From Continuous Operations$-411.472$-346.028$-314.67$-198.471$-117.732$-53.504
Income From Discontinued Operations------
Net Income$-411.472$-346.028$-314.67$-198.471$-117.732$-53.504
EBITDA$-421.441$-359.144$-314.373$-194.504$-114.819$-52.228
EBIT$-426.333$-362.479$-320.794$-200.985$-118.7$-54.133
Basic Shares Outstanding605747393734
Shares Outstanding605747393734
Basic EPS$-6.86$-6.03$-6.75$-5.07$-3.15$-1.59
EPS - Earnings Per Share$-6.86$-6.03$-6.75$-5.07$-3.15$-1.59
# 2020 2019 2018 2017 2016 2015
Current Ratio6.58556.56434.68996.33136.37825.8856
Long-term Debt / Capital0.001-----
Debt/Equity Ratio0.0015-----
Gross Margin98.883198.5199100100100100
Operating Margin-361.5688-384.0349-745.8417-287.5651-200.7815-82.8254
EBIT Margin-361.5688-384.0349-745.8417-287.5651-200.7815-82.8254
EBITDA Margin-357.42-380.5016-730.913-278.2922-194.2168-79.9106
Pre-Tax Profit Margin-348.9653-366.6056-731.6035-283.9681-199.1441-82.5148
Net Profit Margin-348.9653-366.6056-731.6035-283.9681-199.1441-81.863
Asset Turnover0.13240.10990.070.11290.14070.1329
Inventory Turnover Ratio0.17961.6076----
Receiveable Turnover7.69719.039211.71968.40655.09695.1597
Days Sales In Receivables47.420440.379831.144443.418671.612170.7405
ROE - Return On Equity-64.2395-50.3287-83.7996-55.3475-34.1135-12.608
Return On Tangible Equity-64.2395-50.3286-83.7996-55.3475-34.1136-12.608
ROA - Return On Assets-46.1944-40.3081-51.2161-32.0583-28.0271-10.8769
ROI - Return On Investment-64.1721-50.3286-83.7996-55.3475-34.1136-12.608
Book Value Per Share9.364311.80957.69068.49349.155111.4381
Operating Cash Flow Per Share-0.87580.8207-7.10813.0415-0.2931.8959
Free Cash Flow Per Share-0.9570.7983-6.9543.3268-0.76581.9139